{
    "eid": "2-s2.0-85116231623",
    "title": "Early factors for predicting discontinuation to subcutaneous Apomorphine infusion in Parkinson's disease: A prospective analysis of the Thai Apomorphine Registry",
    "cover-date": "2021-10-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Neurology",
            "@code": "2808",
            "@abbrev": "NEUR"
        },
        {
            "@_fa": "true",
            "$": "Geriatrics and Gerontology",
            "@code": "2717",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Neurology (clinical)",
            "@code": "2728",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Apomorphine therapy",
        "Parkinson's disease",
        "Thai apomorphine registry"
    ],
    "authors": [
        "Onanong Phokaewvarangkul",
        "Chanawat Anan",
        "Aukkritthiwat Phimpha",
        "K. Ray Chaudhuri",
        "Teus van Laar",
        "Roongroj Bhidayasiri"
    ],
    "citedby-count": 4,
    "ref-count": 14,
    "ref-list": [
        "Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial",
        "Delivering patient-centered care in Parkinson's disease: challenges and consensus from an international panel",
        "Long-term adherence to apomorphine infusion in patients with Parkinson disease: a 10-year observational study",
        "A 10 year retrospective audit of long-term apomorphine use in Parkinson's disease",
        "Long-term safety and efficacy of apomorphine infusion in Parkinson's disease patients with persistent motor fluctuations: results of the open-label phase of the TOLEDO study",
        "Establishing apomorphine treatment in Thailand: understanding the challenges and opportunities of Parkinson's disease management in developing countries",
        "Long-term apomorphine infusion users versus short-term users: an international dual-center analysis of the reasons for discontinuing therapy",
        "Understanding the role of the Parkinson's disease nurse specialist in the delivery of apomorphine therpy",
        "Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients",
        "Expert Consensus Group for Use of Apomorphine in Parkinson's D et al.: expert Consensus Group report on the use of apomorphine in the treatment of Parkinson's disease--Clinical practice recommendations",
        "Apomorphine: the initial Indian experience in relation to response tests and pumps",
        "Apomorphine monotherapy in the treatment of refractory motor complications of Parkinson's disease: long-term follow-up study of 64 patients",
        "Chronic subcutaneous infusion therapy with apomorphine in advanced Parkinson's disease compared to conventional therapy: a real life study of non motor effect",
        "Continuous subcutaneous apomorphine infusion in Parkinson's disease patients with cognitive dysfunction: a retrospective long-term follow-up study"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "London",
            "@id": "60011520",
            "affilname": "King's College London",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60011520",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Groningen",
            "@id": "60006027",
            "affilname": "Universitair Medisch Centrum Groningen",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006027",
            "affiliation-country": "Netherlands"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "106208652",
            "affilname": "Academy of Science",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/106208652",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Britannia Pharmaceuticals and Stada",
        "Chulalongkorn Academic Advancement Fund",
        "IMI EU",
        "International Research Network",
        "Kirby Laing Foundation",
        "Ratchadapiseksomphot Endowment Fund",
        "Thailand Science",
        "Thailand.Chulalongkorn Centre of Excellence for Parkinson's Disease and Related Disorders",
        "Boehringer-Ingelheim",
        "NPF",
        "Abbott",
        "Roche",
        "AbbVie",
        "Sunovion",
        "Newton Fund",
        "MRC",
        "NIHR",
        "EU",
        "Chulalongkorn University",
        "National Science and Technology Development Agency",
        "Thailand Research Fund",
        "Horizon 2020",
        "Thailand Science Research and Innovation"
    ]
}